Compugroup Medical Ag Stock Price To Book
| 0MSD Stock | 15.95 0.28 1.79% |
CompuGroup Medical AG fundamentals help investors to digest information that contributes to CompuGroup Medical's financial success or failures. It also enables traders to predict the movement of CompuGroup Stock. The fundamental analysis module provides a way to measure CompuGroup Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CompuGroup Medical stock.
CompuGroup | Price To Book |
CompuGroup Medical AG Company Price To Book Analysis
CompuGroup Medical's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, CompuGroup Medical AG has a Price To Book of 0.0 times. This is 100.0% lower than that of the Commercial Services & Supplies sector and about the same as Industrials (which currently averages 0.0) industry. The price to book for all United Kingdom stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
CompuGroup Fundamentals
| Return On Equity | 0.0379 | |||
| Return On Asset | 0.0305 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 1.6 B | |||
| Shares Outstanding | 49.56 M | |||
| Shares Owned By Insiders | 50.35 % | |||
| Shares Owned By Institutions | 22.92 % | |||
| Price To Sales | 1.69 X | |||
| Revenue | 1.19 B | |||
| Gross Profit | 411.71 M | |||
| EBITDA | 215.84 M | |||
| Net Income | 46.87 M | |||
| Total Debt | 766.94 M | |||
| Book Value Per Share | 12.26 X | |||
| Cash Flow From Operations | 179.53 M | |||
| Earnings Per Share | 1.44 X | |||
| Number Of Employees | 8.41 K | |||
| Beta | 0.86 | |||
| Market Capitalization | 2.01 B | |||
| Total Asset | 1.9 B | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 1.9 B | |||
| Last Dividend Paid | 1.0 |
About CompuGroup Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CompuGroup Medical AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CompuGroup Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CompuGroup Medical AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CompuGroup Stock Analysis
When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.